Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma von Lokhorst, Henk M, Plesner, Torben, Laubach, Jacob P, Nahi, Hareth, Gimsing, Peter, Hansson, Markus, Minnema, Monique C, Lassen, Ulrik, Krejcik, Jakub, Palumbo, Antonio, van de Donk, Niels W.C.J, Ahmadi, Tahamtan, Khan, Imran, Uhlar, Clarissa M, Wang, Jianping, Sasser, A. Kate, Losic, Nedjad, Lisby, Steen, Basse, Linda, Brun, Nikolai, Richardson, Paul G

Volltext

A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma von O'Day, S, Pavlick, A, Loquai, C, Lawson, D, Gutzmer, R, Richards, J, Schadendorf, D, Thompson, J A, Gonzalez, R, Trefzer, U, Mohr, P, Ottensmeier, C, Chao, D, Zhong, B, de Boer, C J, Uhlar, C, Marshall, D, Gore, M E, Lang, Z, Hait, W, Ho, P

Volltext

RanBP9 at the intersection between cofilin and Aβ pathologies: rescue of neurodegenerative changes by RanBP9 reduction von Woo, J A, Boggess, T, Uhlar, C, Wang, X, Khan, H, Cappos, G, Joly-Amado, A, De Narvaez, E, Majid, S, Minamide, L S, Bamburg, J R, Morgan, D, Weeber, E, Kang, D E

Volltext

P32 MAJESTEC‐1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B‐CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)... von Donk, N., Cortes‐Selva, D., Casneuf, T., Vishwamitra, D., Stein, S., Perova, T., Ramos, E., Van Steenbergen, L., Boominathan, R., Lau, O., Davis, C., Banerjee, A., Stephenson, T., Uhlar, C., Kobos, R., Goldberg, J., Pei, L., Trancucci, D., Girgis, S., Lin, S.X.W., Wu, L.S., Moreau, P., Usmani, S., Bahlis, N.J., Verona, R.

Volltext

S184: EVALUATING TECLISTAMAB IN PATIENTS WITH RELAPSED/ REFRACTORY MULTIPLE MYELOMA FOLLOWING EXPOSURE TO OTHER B‐CELL MATURATION ANTIGEN (BCMA)‐TARGETED AGENTS von Touzeau, C., Krishnan, A., Moreau, P., Perrot, A., Usmani, S. Z., Manier, S., Cavo, M., Martinez‐Chamorro, C., Nooka, A., Martin, T., Karlin, L., Leleu, X., Bahlis, N., Besemer, B., Pei, L., Verona, R., Girgis, S., Uhlar, C., Kobos, R., Garfall, A.

Volltext

P921: UPDATED EFFICACY AND SAFETY RESULTS OF TECLISTAMAB, A B‐CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC... von Martínez‐López, J., Moreau, P., Usmani, S. Z., Garfall, A., Donk, N. W., San‐Miguel, J. F., Oriol, A., Chari, A., Karlin, L., Mateos, M.‐V., Popat, R., Nooka, A. K., Sidana, S., Trancucci, D., Verona, R., Girgis, S., Uhlar, C., Stephenson, T., Banerjee, A., Krishnan, A.

Volltext

P06: UPDATED RESULTS FROM THE PHASE 1/2 MAJESTEC‐1 STUDY OF TECLISTAMAB, A B‐CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOM... von Popat, R, Usmani, S, Garfall, A, Donk, N, Nahi, H, San‐Miguel, J, Oriol, A, Nooka, A, Martin, T, Rosinol, L, Chari, A, Karlin, L, Benboubker, L, Mateos, M, Bahlis, N, Moreau, P, Besemer, B, Martínez‐López, J, Sidana, S, Pei, L, Trancucci, D, Verona, R, Girgis, S, Olyslager, Y, Jaffe, M, Uhlar, C, Stephenson, T, Van Rampelbergh, R, Banerjee, A, Goldberg, J, Kobos, R, Krishnan, A

Volltext

Serum amyloid A, the major vertebrate acute‐phase reactant von Uhlar, Clarissa M., Whitehead, Alexander S.

Volltext

Teclistamab in Relapsed or Refractory Multiple Myeloma von Moreau, Philippe, Garfall, Alfred L., van de Donk, Niels W.C.J., Nahi, Hareth, San-Miguel, Jesús F., Oriol, Albert, Nooka, Ajay K., Martin, Thomas, Rosinol, Laura, Chari, Ajai, Karlin, Lionel, Benboubker, Lotfi, Mateos, Maria-Victoria, Bahlis, Nizar, Popat, Rakesh, Besemer, Britta, Martínez-López, Joaquín, Sidana, Surbhi, Delforge, Michel, Pei, Lixia, Trancucci, Danielle, Verona, Raluca, Girgis, Suzette, Lin, Shun X.W., Olyslager, Yunsi, Jaffe, Mindy, Uhlar, Clarissa, Stephenson, Tara, Van Rampelbergh, Rian, Banerjee, Arnob, Goldberg, Jenna D., Kobos, Rachel, Krishnan, Amrita, Usmani, Saad Z.

Volltext

Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma von Facon, Thierry, Kumar, Shaji, Plesner, Torben, Orlowski, Robert Z, Moreau, Philippe, Bahlis, Nizar, Basu, Supratik, Nahi, Hareth, Hulin, Cyrille, Quach, Hang, Goldschmidt, Hartmut, O’Dwyer, Michael, Perrot, Aurore, Venner, Christopher P, Weisel, Katja, Mace, Joseph R, Raje, Noopur, Attal, Michel, Tiab, Mourad, Macro, Margaret, Frenzel, Laurent, Leleu, Xavier, Ahmadi, Tahamtan, Chiu, Christopher, Wang, Jianping, Van Rampelbergh, Rian, Uhlar, Clarissa M, Kobos, Rachel, Qi, Ming, Usmani, Saad Z

Volltext

Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, ope... von Facon, Thierry, Kumar, Shaji K, Plesner, Torben, Orlowski, Robert Z, Moreau, Philippe, Bahlis, Nizar, Basu, Supratik, Nahi, Hareth, Hulin, Cyrille, Quach, Hang, Goldschmidt, Hartmut, O'Dwyer, Michael, Perrot, Aurore, Venner, Christopher P, Weisel, Katja, Mace, Joseph R, Raje, Noopur, Tiab, Mourad, Macro, Margaret, Frenzel, Laurent, Leleu, Xavier, Ahmadi, Tahamtan, Wang, Jianping, Van Rampelbergh, Rian, Uhlar, Clarissa M, Tromp, Brenda, Delioukina, Maria, Vermeulen, Jessica, Usmani, Saad Z

Volltext

Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma von Usmani, Saad Z., Weiss, Brendan M., Plesner, Torben, Bahlis, Nizar J., Belch, Andrew, Lonial, Sagar, Lokhorst, Henk M., Voorhees, Peter M., Richardson, Paul G., Chari, Ajai, Sasser, A.Kate, Axel, Amy, Feng, Huaibao, Uhlar, Clarissa M., Wang, Jianping, Khan, Imran, Ahmadi, Tahamtan, Nahi, Hareth

Volltext

Evolution of the Serum Amyloid A (SAA) Protein Superfamily von Uhlar, Clarissa M., Burgess, Conal J., Sharp, Paul M., Whitehead, Alexander S.

Volltext

Acute phase proteins in salmonids: evolutionary analyses and acute phase response von Jensen, LE, Hiney, MP, Shields, DC, Uhlar, CM, Lindsay, AJ, Whitehead, AS

Volltext

Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma von Moreau, Philippe, van de Donk, Niels Wcj, Nahi, Hareth, Oriol, Albert, Nooka, Ajay K, Martin, Thomas, Rosinol, Laura, Karlin, Lionel, Benboubker, Lotfi, Mateos, Maria-Victoria, Popat, Rakesh, Martínez-López, Joaquín, Sidana, Surbhi, Delforge, Michel, Pei, Lixia, Trancucci, Danielle, Olyslager, Yunsi, Uhlar, Clarissa, Stephenson, Tara, Rampelbergh, Rian Van, Banerjee, Arnob, Kobos, Rachel, Usmani, Saad Z

Volltext

Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial von Perrot, Aurore, Facon, Thierry, Plesner, Torben, Usmani, Saad Z., Kumar, Shaji, Bahlis, Nizar J., Hulin, Cyrille, Orlowski, Robert Z., Nahi, Hareth, Mollee, Peter, Ramasamy, Karthik, Roussel, Murielle, Jaccard, Arnaud, Delforge, Michel, Karlin, Lionel, Arnulf, Bertrand, Chari, Ajai, He, Jianming, Ho, Kai Fai, Van Rampelbergh, Rian, Uhlar, Clarissa M., Wang, Jianping, Kobos, Rachel, Gries, Katharine S., Fastenau, John, Weisel, Katja

Volltext

Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA von Facon, Thierry, Cook, Gordon, Usmani, Saad Z., Hulin, Cyrille, Kumar, Shaji, Plesner, Torben, Touzeau, Cyrille, Bahlis, Nizar J., Basu, Supratik, Nahi, Hareth, Goldschmidt, Hartmut, Quach, Hang, Mohty, Mohamad, Venner, Christopher P., Weisel, Katja, Raje, Noopur, Hebraud, Benjamin, Belhadj-Merzoug, Karim, Benboubker, Lotfi, Decaux, Olivier, Manier, Salomon, Caillot, Denis, Ukropec, Jon, Pei, Huiling, Van Rampelbergh, Rian, Uhlar, Clarissa M., Kobos, Rachel, Zweegman, Sonja

Volltext

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial von Lonial, Sagar, Prof, Weiss, Brendan M, Prof, Usmani, Saad Z, Prof, Singhal, Seema, Prof, Chari, Ajai, Prof, Bahlis, Nizar J, Prof, Belch, Andrew, Prof, Krishnan, Amrita, Prof, Vescio, Robert A, Prof, Mateos, Maria Victoria, Prof, Mazumder, Amitabha, Prof, Orlowski, Robert Z, Prof, Sutherland, Heather J, Prof, Bladé, Joan, Prof, Scott, Emma C, Prof, Oriol, Albert, MD, Berdeja, Jesus, MD, Gharibo, Mecide, Prof, Stevens, Don A, MD, LeBlanc, Richard, Prof, Sebag, Michael, Prof, Callander, Natalie, Prof, Jakubowiak, Andrzej, Prof, White, Darrell, Prof, de la Rubia, Javier, Prof, Richardson, Paul G, Prof, Lisby, Steen, MD, Feng, Huaibao, PhD, Uhlar, Clarissa M, PhD, Khan, Imran, MD, Ahmadi, Tahamtan, MD, Voorhees, Peter M, Prof

Volltext

Daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma: final results from the phase 2 GEN501 and SIRIUS trials von Usmani, Saad Z, Nahi, Hareth, Plesner, Torben, Weiss, Brendan M, Bahlis, Nizar J, Belch, Andrew, Voorhees, Peter M, Laubach, Jacob P, van de Donk, Niels W C J, Ahmadi, Tahamtan, Uhlar, Clarissa M, Wang, Jianping, Feng, Huaibao, Qi, Ming, Richardson, Paul G, Lonial, Sagar

Volltext

The Kinetics and Magnitude of the Synergistic Activation of the Serum Amyloid A Promoter by IL‐1β and IL‐6 is Determined by the Order of Cytokine Addition von Uhlar, C M, Whitehead, A S

Volltext